Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tateyama Masato"'
Autor:
Tateyama, Masato1, Kudo, Ikuo2, Hashimoto, Motohide3, Abe, Yasuyuki4, Kainuma, Akira5, Yoshimura, Kimio6, Asai, Masahiro6, Bartels, Mathias7, Kasper, Siegfried8
Publikováno v:
Psychopathology. Mar-Apr1999, Vol. 32 Issue 2, p98-106. 9p.
Autor:
Tateyama, Masato1, Asai, Masahiro2, Hashimoto, Motohide3, Bartels, Mathias4, Kasper, Siegfried5
Publikováno v:
Psychopathology. Mar-Apr1998, Vol. 31 Issue 2, p59-68. 10p.
Autor:
Tateyama, Masato1, Asai, Masahiro2, Kamisada, Mamoru3, Hashimoto, Motohide3, Bartels, Mathias4, Heimann, Hans4
Publikováno v:
Psychopathology. 1993, Vol. 26 Issue 3/4, p151-158. 8p.
Autor:
Fujii, Yasuo, Tateyama, Masato, Kamisada, Mamoru, Tanoue, Akira, Takamiya, Maki, Nakajima, Seiichiro, Itoh, Hitoshi
Publikováno v:
Psychiatry & Clinical Neurosciences; Jun1984, Vol. 38 Issue 2, p121-136, 16p
Autor:
Fujii Yasuo, Yamazumi Shun, Ohtsuka Nobuo, Koga Yoshihiko, Ogita Kazuhiro, Sakurai Shunsuke, Satoh Kiichiro, Itoh Hitoshi, Yagi Gohei, Suzuki Yasuyo, Tateyama Masato, Kamishima Kunitoshi, Saitoh Fumio, Nakano Yoshiki, Tanoue Satory, Kamisada Mamoru, Takamiya Maki, Miura Sadanori, Masuda Yutaka, Yoshida Hiromune, Nabeta Yasutaka
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 8:39-49
An epidemiological study was undertaken, taking a survey of 2,274 chronic schizophrenic patients hospitalized for 2 years or more in 17 mental institutions in Japan. The overall prevalence of tardive dyskinesia (T.D.) was 19.1%. The prevalence of TD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e4827c5db2b98046e2142d5a3811680
https://doi.org/10.1016/0278-5846(84)90134-9
https://doi.org/10.1016/0278-5846(84)90134-9
Publikováno v:
Progress in neuro-psychopharmacologybiological psychiatry. 8(1)
1. Haloperidol serum levels were determined by the recently developed radioimmunoassay technique to elucidate the relationship between serum levels and clinical effects and that between serum levels and adverse effects. 2. The serum levels of haloper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4492ec7399d7910729e2458d17d5f5c
https://pubmed.ncbi.nlm.nih.gov/6539490
https://pubmed.ncbi.nlm.nih.gov/6539490